BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Accenture
Deloitte
Harvard Business School
Healthtrust
Cipla
Cerilliant
Merck
Julphar
Novartis

Generated: January 21, 2018

DrugPatentWatch Database Preview

MEPIVACAINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Mepivacaine Hydrochloride, and what generic alternatives are available?

Mepivacaine Hydrochloride is a drug marketed by Belmora Llc, Hospira Inc, Intl Medication Sys, and Watson Labs. and is included in six NDAs.

The generic ingredient in MEPIVACAINE HYDROCHLORIDE is levonordefrin; mepivacaine hydrochloride. There are two drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the levonordefrin; mepivacaine hydrochloride profile page.

US Patents and Regulatory Information for MEPIVACAINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Belmora Llc MEPIVACAINE HYDROCHLORIDE mepivacaine hydrochloride INJECTABLE;INJECTION 083559-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs MEPIVACAINE HYDROCHLORIDE mepivacaine hydrochloride INJECTABLE;INJECTION 088769-001 Nov 20, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira Inc MEPIVACAINE HYDROCHLORIDE mepivacaine hydrochloride INJECTABLE;INJECTION 040806-001 Apr 28, 2008 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Intl Medication Sys MEPIVACAINE HYDROCHLORIDE mepivacaine hydrochloride INJECTABLE;INJECTION 087509-001 Oct 5, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Belmora Llc MEPIVACAINE HYDROCHLORIDE W/ LEVONORDEFRIN levonordefrin; mepivacaine hydrochloride INJECTABLE;INJECTION 084850-002 Oct 21, 1983 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs MEPIVACAINE HYDROCHLORIDE mepivacaine hydrochloride INJECTABLE;INJECTION 088770-001 Nov 20, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
Mallinckrodt
Deloitte
QuintilesIMS
Harvard Business School
Daiichi Sankyo
Boehringer Ingelheim
Express Scripts
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot